WBJournal

Harvard Bioscience Inc.

Holliston biotechnology firm Harvard Bioscience continued its fourth quarter momentum with revenue up 14% in the first quarter of 2021 when compared to the first quarter of 2020. Holliston ...
Nasdaq

Examining the Future: Harvard Bioscience's Earnings Outlook

Harvard Bioscience (NASDAQ:HBIO) is set to give its latest quarterly earnings report on Monday, 2025-05-12. Here's what investors need to know before the announcement. Analysts estimate that Harvard ...
Hosted on MSN

Keybanc Downgrades Harvard Bioscience (HBIO)

Fintel reports that on April 9, 2025, Keybanc downgraded their outlook for Harvard Bioscience (NasdaqGM:HBIO) from Overweight to Sector Weight. Analyst Price Forecast Suggests 944.80% Upside As of ...
Seeking Alpha

Harvard Bioscience: Looking To Reload After Post-Q2 Earnings Sell-Off

Harvard Bioscience's Q2 earnings showed a slight miss on EPS and revenue, causing a decline in the stock price. The company is committed to improving its product portfolio and has observed increased ...
The National Law Review

Harvard Bioscience Announces CFO Transition

HOLLISTON, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Jennifer Cote, the Company’s Chief Financial Officer and ...
Yahoo Finance

Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package

HOLLISTON, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”), today announced it ...
Hosted on MSN

Harvard Bioscience engages in credit agreement discussions

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Nasdaq

Harvard Bioscience, Inc. to Announce Q1 2025 Financial Results on May 12, 2025

Harvard Bioscience, Inc. (Nasdaq: HBIO) will release its financial results for the first quarter of 2025 on May 12, 2025, before the market opens, followed by a conference call at 8:00 a.m. Eastern ...
Seeking Alpha

Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board

Current Board member John Duke to succeed Jim Green as President & CEO Rob Gagnon and Seth Benson appointed as new Board members Q2 ’25 revenue anticipated to be $20.4 million and Company reiterates ...
Business Insider

Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors

HOLLISTON, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”) today announced the appointment of Stephen DeNelsky to its Board of ...
MarketWatch

Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States

The MarketWatch News Department was not involved in the creation of this content. HOLLISTON, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the "Company" or ...
WBJournal

Harvard Bioscience Inc.

Jim Green will retire from his roles as chairman, president, and CEO of Harvard Bioscience on July 28. Harvard Bioscience falls out of Nasdaq compliance after board member resignation Harvard ...